Accordingly, reducing the level of mtROS to block C. pneumoniae infection-induced VSMC migration-related signal axis, JunB-Fra-1/MMP2 signal axis, may become a potential treatment target for C. pneumoniae infection-induced atherosclerosis. The gene discussed is MMP2; the disease is atherosclerosis.